Company Sorbanmed S.r.l. with Fiscal Code 35369834
recorded a turnover of 2024 of
54.567,
with a net profit of
27.859
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sorbanmed S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
18.851
22.774
25.721
29.602
26.023
30.000
37.825
49.333
54.567
Total Income - EUR
-
18.851
22.774
25.721
29.602
27.683
37.911
37.874
49.333
54.567
Total Expenses - EUR
-
6.694
7.658
7.953
8.661
10.367
9.125
14.383
17.233
25.104
Gross Profit/Loss - EUR
-
12.157
15.116
17.769
20.940
17.316
28.786
23.491
32.100
29.463
Net Profit/Loss - EUR
-
11.591
14.433
16.997
20.052
16.593
27.818
22.379
27.178
27.859
Employees
-
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 11.2%, from 49.333 euro in the year 2023, to 54.567 euro in 2024.
The Net Profit increased by 833 euro, from 27.178 euro in 2023, to 27.859 in the last year.
Check the financial reports for the company - Sorbanmed S.r.l.
Financial Rating - SORBANMED S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sorbanmed S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sorbanmed S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sorbanmed S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
31.144 euro in 2024 which includes Inventories of
0 euro, Receivables of
3.574 euro and cash availability of
27.570 euro.
The company's Equity was valued at
28.067 euro, while total Liabilities amounted to
9.284 euro.
Equity decreased by -8.729 euro, from 37.003 euro in 2023, to 28.067 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sorbanmed S.r.l.